Pyridoindole SMe1EC2 as cognition enhancer in ageing-related cognitive decline
Authors
Nataša Mrvová
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Martin Škandík
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Štefan Bezek
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Natália Sedláčková
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Mojmír Mach
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Zdenka Gaspárová
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Dominika Luptáková
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Ivan Padej
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Lucia Račková
Institute of Experimental Pharmacology and Toxicology, Slovak Academy of Sciences, Bratislava, Slovakia
Language: English
Page range: 11 - 19
Submitted on: May 13, 2016
Accepted on: Jul 10, 2017
Published on: Feb 14, 2018
In partnership with: Paradigm Publishing Services
Publication frequency: 4 issues per year
Keywords:
Related subjects:
© 2018 Nataša Mrvová, Martin Škandík, Štefan Bezek, Natália Sedláčková, Mojmír Mach, Zdenka Gaspárová, Dominika Luptáková, Ivan Padej, Lucia Račková, published by Slovak Academy of Sciences, Institute of Experimental Pharmacology & Toxicology, Centre of Experimental Medicine
This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 License.